Genscript

GenScript is a leading synthetic biology and life sciences company headquartered in Nanjing, China, founded in 2002 by Jie Chen. The company provides gene synthesis, protein expression optimization, and cell engineering services to pharmaceutical, biotech, and academic customers worldwide. Publicly traded on Nasdaq under ticker DNA, GenScript operates globally with major offices in the United States, Europe, and Asia, employing approximately 3,500 people. The company has established itself as a key enabling platform in the biotechnology industry, offering both services and tools that accelerate drug discovery and development. Recent strategic moves including acquisitions in protein engineering and expansion of manufacturing capacity position GenScript as a critical infrastructure provider for the biotech sector.